This bill establishes new requirements for pharmacy benefit managers and health carriers regarding clinician-administered drugs in Minnesota. It defines key terms such as "affiliated pharmacy" and "clinician-administered drug," and prohibits pharmacy benefit managers and health carriers from requiring that these drugs be covered as a pharmacy benefit. The bill ensures that enrollees have the right to obtain clinician-administered drugs from their chosen healthcare provider or pharmacy without interference or financial incentives from the pharmacy benefit manager or health carrier.

Additionally, the bill outlines provisions related to cost-sharing and reimbursement, stating that any limitations or cost-sharing requirements imposed on enrollees must be consistent regardless of whether the drug is obtained from an affiliated pharmacy or a selected pharmacy. It also includes other requirements to ensure compliance with federal supply chain security laws and allows for the optional use of home infusion pharmacies. The new regulations will take effect on January 1, 2024.